Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot O75112: Variant p.Thr206Ile

LIM domain-binding protein 3
Gene: LDB3
Feedback?
Variant information Variant position: help 206 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Threonine (T) to Isoleucine (I) at position 206 (T206I, p.Thr206Ile). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and polar (T) to medium size and hydrophobic (I) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In CMD1C. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 206 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 727 The length of the canonical sequence.
Location on the sequence: help LPGSSQPRQYNNPIGLYSAE T LREMAQMYQMSLRGKASGVG The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         LPGSSQPRQYNNPIGLYSAETLREMAQMYQMSLRGKASGVG

Mouse                         LPGPSQPRQYNNPIGLYSAETLREMAQMYQMSLRGKASGAG
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 727 LIM domain-binding protein 3
Modified residue 217 – 217 Phosphoserine
Modified residue 219 – 219 Omega-N-methylarginine
Modified residue 223 – 223 Phosphoserine
Alternative sequence 108 – 364 Missing. In isoform 3.
Alternative sequence 108 – 229 DPALDTNGSLVAPSPSPEARASPGTPGTPELRPTFSPAFSRPSAFSSLAEASDPGPPRASLRAKTSPEGARDLLGPKALPGSSQPRQYNNPIGLYSAETLREMAQMYQMSLRGKASGVGLPG -> VVVNSPANADYQERFNPSALKDSALSTHKPIEVKGLGGKATIIHAQYNTPISMYSQDAIMDAIAGQAQAQGSDFS. In isoform 2 and isoform 6.



Literature citations
Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction.
Vatta M.; Mohapatra B.; Jimenez S.; Sanchez X.; Faulkner G.; Perles Z.; Sinagra G.; Lin J.-H.; Vu T.M.; Zhou Q.; Bowles K.R.; Di Lenarda A.; Schimmenti L.; Fox M.; Chrisco M.A.; Murphy R.T.; McKenna W.; Elliott P.; Bowles N.E.; Chen J.; Valle G.; Towbin J.A.;
J. Am. Coll. Cardiol. 42:2014-2027(2003)
Cited for: VARIANTS CMD1C LEU-189; ILE-206 AND MET-345; VARIANTS CMD1C ASN-117 AND MET-136 (ISOFORMS 2 AND 4);
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.